Biobase in Stock Automatic Chemiluminescence Immunoassay System Clia Analyzer for Lab

Name: Biobase in Stock Automatic Chemiluminescence Immunoassay System Clia Analyzer for Lab
Brand: Biobase Biolin Co., Ltd.
SKU: 1975163212

Shandong, ChinaBiobase Biolin Co., Ltd.

US$6,000.00-20,000.00

1 Set

Sample price:US$9900.00/piece.Request sample

Product profile

Customization

Available

Classification

Biological Diagnostics

Type

Automatic Chemiluminescence Immunoassay System

Model NO.

BKI1100

Certification

CE, FDA, ISO13485, /

Group

All

Product Name

Automatic Chemiluminescence Immunoassay System

Throughput

120t/H

Principle

Magnetic Particle Enzymatic Chemiluminescence

Modes of Operation

Random, Batch and Stat

Separation Method

Magnetic Separation Technology

Sample Positions

60 (Each Position Could Be Used as an Emergency Po

Reagent Positions

30 PCS (2-8c Refrigeration)

Incubation Positions

Time to 1st Result

18 Minutes

Detection Precision

CV<5%

Transport Package

We Provide a Variety of Packaging Methods Such as

Specification

127KG

Trademark

BIOBASE

Origin

China

Production Capacity

10000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceMulti-language PioneerExperienced Team

Biobase Biolin Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 8.5 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤3.90h

AI-Powered supplier vetting

SummaryThe supplier is identified as a limited trading company in Jinan, offering laboratory equipment, medical devices, biochemistry analyzers, autoclaves, biological safety cabinets, and related products. It reports ODM, OEM, professional technical, 3D design, and flexible customization capabilities, along with overseas service offerings and a stated export-sales share of 90%. Service procedures are mixed: complaint handling and corrective/preventive action procedures have records, while effective service-capability assessment procedures lack written procedures and records. No overseas showroom, agent, branch, offline trade-show participation, SDK, or new-product launch is reported. Production quantities are stated for three products, but the supplier’s manufacturing status is unclear because it is classified as a trading company.

Supplier typeThe supplier is explicitly classified as a Trading Company and Limited Company, with a business scope centered on sales of medical equipment, office supplies, software, electronic products, and related items. It is not identified as part of a larger company group, and its associated industry is wholesale and retail.

After-Sales capabilityThe supplier reports overseas training, equipment installation, repair, maintenance, and debugging services, with 10 qualified service suppliers and stated lead times of within 15 working days off-season and one month during peak season. Complaint handling and corrective/preventive-action procedures have records, but the assessment procedure for effective service capability lacks written procedures and records; there are also no overseas showrooms, agents, branches, or offline trade-show experience.

R&D capabilityThe supplier reports ODM service, professional technical R&D capability, 3D software design, and flexible customization. However, it reports no new products launched in the past year and no available SDK, while product-information R&D capability is also marked as absent.

Customization capabilityThe supplier explicitly provides ODM services, 3D software design services, and flexible customization through its design and R&D capabilities. These statements directly support the availability of customized design or product solutions.